两家公司表示,在合作的初始阶段,Ares开发了一个数字抗感染平台,将微生物学实验室实践与先进的生物信息学和人工智能方法相结合,以帮助识别有效的抗菌化合物...查看全文
蹊之美股生物医药2021-10-08 00:15
作者:林出
微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Voyager Therapeutics (NASDAQ:VYGR) +56%
Acer Therapeutics (NASDAQ:ACER) +16%
Molecular Partners (NASDAQ:MOLN) +10%
Rafael (NYSE:RFL) +6%
Arcturus Therapeutics (NASDA...查看全文
东哥_Singapore2021-03-08 23:42
$Jaguar Health(JAGX)$ 给力点啊,速度冲2.5!刚才在2.9的OPGN跟1.85的你之间,最后选的你!不要让我失望啊!OPGN已经爆拉了!!!$OpGen(OPGN)$查看全文
$OpGen(OPGN)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001079973-21-001092 Act: 34 Size: 27 KB 网页链接
$OpGen(OPGN)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001079973-21-001089 Act: 34 Size: 259 KB 网页链接
$OpGen(OPGN)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001079973-21-001090 Act: 34 Size: 58 KB 网页链接
$OpGen(OPGN)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001079973-21-001075 Act: 34 Size: 28 KB 网页链接
$OpGen(OPGN)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001079973-21-001077 Act: 34 Size: 28 KB 网页链接
$OpGen(OPGN)$ DEF 14A Other definitive proxy statements Accession Number: 0001079973-21-001073 Act: 34 Size: 218 KB 网页链接
$OpGen(OPGN)$ PRE 14A Other preliminary proxy statements Accession Number: 0001079973-21-001043 Act: 34 Size: 256 KB 网页链接
$OpGen(OPGN)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001079973-21-001034 Act: 33 Size: 347 KB 网页链接
$OpGen(OPGN)$ 8-K Current report, items 1.01, 3.03, 5.03, 8.01, and 9.01 Accession Number: 0001079973-21-001032 Act: 34 Size: 791 KB 网页链接
$OpGen(OPGN)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001079973-21-000999 Act: 34 Size: 243 KB 网页链接